202 related articles for article (PubMed ID: 4567562)
21. [Liver of psoriatic patients treated with methotrexate].
Kraus Z; Vortel V; Fixa B; Komárková O
Cesk Dermatol; 1973 Aug; 48(4):255-62. PubMed ID: 4727832
[No Abstract] [Full Text] [Related]
22. Experiences with methotrexate in psoriasis.
Frank L; Lichtman H; Biro L; Petrou P
Dermatologica; 1968; 137(2):87-96. PubMed ID: 5668252
[No Abstract] [Full Text] [Related]
23. Hepatotoxicity of long-term methotrexate therapy for psoriasis.
Tobias H; Auerbach R
Arch Intern Med; 1973 Sep; 132(3):391-6. PubMed ID: 4783020
[No Abstract] [Full Text] [Related]
24. [Laboratory and oligobiopsy examination of the liver in patients with psoriasis treated with methotrexate (preliminary report)].
Ruszczak Z; Prószyńska-Kuczyńska W; Babiński S; Biernat S; Kulig A
Przegl Dermatol; 1974; 61(6):803-7. PubMed ID: 4431967
[No Abstract] [Full Text] [Related]
25. Systemic chemotherapy for psoriasis: a national survey.
Bergstresser PR; Schreiber SH; Weinstein GD
Arch Dermatol; 1976 Jul; 112(7):977-81. PubMed ID: 947151
[TBL] [Abstract][Full Text] [Related]
26. [Damage due to treatment of psoriasis with folic acid antagonists].
Randazzo SD; Chiarenza A; Lazzaro C
G Ital Dermatol Minerva Dermatol; 1972 Feb; 47(2):77-81. PubMed ID: 4260377
[No Abstract] [Full Text] [Related]
27. Methrotrexate U.S.P. (amethopterin) and methotrexate sodium.
Am J Hosp Pharm; 1973 Jun; 30(6):542-8. PubMed ID: 4709936
[No Abstract] [Full Text] [Related]
28. Low-dose methotrexate toxicity.
Pivovarov K; Zipursky JS
CMAJ; 2019 Apr; 191(15):E423. PubMed ID: 30988043
[No Abstract] [Full Text] [Related]
29. Some hazards of methotrexate treatment of psoriasis.
Baker H
Trans St Johns Hosp Dermatol Soc; 1970; 56(2):111-6. PubMed ID: 4930355
[No Abstract] [Full Text] [Related]
30. Severe liver damage caused by treatment of psoriasis with methotrexate.
Pai SH; Werthamer S; Zak FG
N Y State J Med; 1973 Nov; 73(21):2585-7. PubMed ID: 4518596
[No Abstract] [Full Text] [Related]
31. Treatment of moderate-to-severe plaque psoriasis.
Salgo R; Thaçi D
G Ital Dermatol Venereol; 2009 Dec; 144(6):701-11. PubMed ID: 19907408
[TBL] [Abstract][Full Text] [Related]
32. [Liver biopsy studies in long-term therapy of psoriasis using methotrexate].
Dietz O; Pachaly A; Schillat I
Dermatol Monatsschr; 1974 Aug; 160(8):634-42. PubMed ID: 4216519
[No Abstract] [Full Text] [Related]
33. Letter: Methotrexate dosage schedule.
Rees RB
Arch Dermatol; 1974 Mar; 109(3):407. PubMed ID: 4814944
[No Abstract] [Full Text] [Related]
34. The relation of HL-A antigens to liver histology in methotrexate-treated psoriatics.
Nyfors A; Svejgaard A
Acta Derm Venereol; 1976; 56(3):235-8. PubMed ID: 59509
[TBL] [Abstract][Full Text] [Related]
35. [Methotrexate in the treatment of psoriasis].
Grupper C; Bourgeois-Spinasse J
Presse Med (1893); 1970 Sep; 78(37):1631-4. PubMed ID: 5455160
[No Abstract] [Full Text] [Related]
36. A prospective study of the effects of weekly oral methotrexate on liver biopsy.
Warin AP; Landells JW; Levene GM; Baker H
Br J Dermatol; 1975 Sep; 93(3):321-7. PubMed ID: 1103936
[TBL] [Abstract][Full Text] [Related]
37. Psoriasis, methotrexate, and cirrhosis.
JAMA; 1970 Apr; 212(2):314-5. PubMed ID: 5467236
[No Abstract] [Full Text] [Related]
38. Pseudoleukemia during recovery from methotrexate toxicity in psoriasis.
Gailani DS
N Y State J Med; 1972 May; 72(9):1054-6. PubMed ID: 4502393
[No Abstract] [Full Text] [Related]
39. Hepatotoxicity of methotrexate in the treatment of psoriasis.
Roenigk HH; Bergfeld WF; St Jacques R; Owens FJ; Hawk WA
Arch Dermatol; 1971 Mar; 103(3):250-61. PubMed ID: 5548272
[No Abstract] [Full Text] [Related]
40. Pulmonary and hepatic complications of methotrexate therapy of psoriasis.
Filip DJ; Logue GL; Harle TS; Farrar WH
JAMA; 1971 May; 216(5):881-2. PubMed ID: 5108291
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
